Publications

How Do Clinical Wearables Impact Patient Care and Quality of Life?

Read more

Exploring Serious Market Access Roadblocks for Rare Bleeding Disorders

Read more

Addressing Market Access Obstacles in Relation to Rare Bleeding Disorders

Read more

Strategies for Successful Market Access in the Untapped NASH Market

Read more

The Patient Journey: A Tool for Market Access?

Read more

Unraveling the Potential of Real-World Studies

Read more

Unraveling the Potential of Real-World Studies

Read more

Access to Orphan Drugs for Rare Cancers in EU28

Read more

Market Access Strategies for Apac Biosimilars

Read more

Are European Incentives Speeding Access in Rare Cancer Treatments?

Read more

We Can Eradicate Hepatitis C in the Emerging World – Here’s How

Read more

Prevalence of Hepatitis B and C among Blood Donors in Makurdi, Benue State, Nigeria

Read more

Hepatitis Awareness among the Students of a Women’s College in Bangalore, India

Read more

HCV Codex – An Overview of Epidemiology, Clinical Features and Diagnosis

Read more

A Short Survey on the Choice of Information Preferred

Read more

Leveraging Ubiquitous and Novel Technologies as Enablers to Address Africa’s Health Challenges

Read more

Hepatitis Awareness among the General Public in Cameroon – A Survey

Read more

Prevalence of HBV and HIV among Students and Staff at the University of Jos, Nigeria – Results from a Medical Outreach Screening Program

Read more

The Patient Registry – A High Impact Tool for Real World Evidence

Read more

Pharmaceutical Market Access in Emerging Markets

Read more

Healthcare Costs and Access to Care for Viral Hepatitis in Ethiopia

Read more

mEI (Evolution Index-mature products) – Redefined for Pharmaceutical Business Analytics

Read more

The Quest for Cost Effective Treatment in Rheumatoid Arthritis – Are Biosimilars the Right Choice?

Read more

A Study to Assess the Awareness of Biosimilars among Ukrainian Physicians

Read more

Technical Hindrances in Establishing Biosimilarity – The Final Lap in the Race

Read more

Legislations on Biosimilar Interchangeability in the US and the EU – Developments Far from Visibility

Read more

Market Access Advancements and Challenges in Drug Companion Diagnostic Test Co-Development in Europe

Read more

Legislations on Biosimilar Interchangeability in the US and the EU – Developments Far from Visibility

Read more

Optimal eCRf Design, User Friendly Interface and Proper Training – Quintessential for High Quality Data in Real World Evidence (RWE) Studies

Read more

Real World Evidence – A Form of Big Data – Transforming Healthcare Data into Actionable Real Time Insights and Informed Business Decisions

Read more
Next Page »

Reports

Bulletins

Case Studies

Infographics